サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Biologics Safety Testing Market Research Report - Global Forecast till 2023

生物製剤安全性試験市場調査レポート-2023年までの世界予測

レポート概要

世界の生物製剤安全性試験市場レポート:製品別(キット&試薬、器具類、サービス)、試験別(無菌、エンドトキシン、細胞株認証)、用途別(ワクチン開発、血液製剤、幹細胞研究)‐2023年までの世界予測

市場シナリオ

世界の生物製剤安全性検査市場は予測期間中、大幅な伸びが予想され、2017年の27億9,000万ドルから13.6%のCAGRで拡大が見込まれます。生物製剤安全性検査は全てのバイオ医薬品とワクチンに必要です。最近では、2016年にCDERは22の新薬を承認したのに対し、2017年には46の製品を承認しました。

医薬品及びバイオテクノロジー産業の成長、医薬品の発売件数の増加、ライフサイエンスにおける研究開発投資の増加などがこの市場の成長を加速させることが予想されます。一方で、バイオ市ミラーの承認に対する国の厳しい規制と高い医薬品開発コストが成長を妨げる要因となります。

レポート詳細

目次

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis

Chapter 6. Global Biologics Safety Testing Market, by Product
6.1 Introduction
6.2 Kits & Reagents
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
6.3 Services
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
6.4 Instruments
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023

Chapter 7. Global Biologics Safety Testing Market, by Test Type
7.1 Introduction
7.2 Sterility Tests
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.3 Endotoxin Tests
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.4 Cell Line Authentication and Characterization Tests
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.5 Residual Host Contamination Detection Tests
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.6 Adventitious Agent Detection Tests
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.7 Bioburden Tests
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
7.8 Others
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023

Chapter 8. Global Biologics Safety Testing Market, by Application
8.1 Introduction
8.2 Vaccine And Therapeutics Development
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.3 Blood and Blood-Related Products Testing
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.4 Cellular and Gene Therapy
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.5 Tissue and Tissue-Related Products Testing
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023
8.6 Stem Cell Research
Market Estimates & Forecast, by Region, 2018-2023
Market Estimates & Forecast, by Country, 2018-2023

Chapter 9. Global Biologics Safety Testing Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa

Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies

Chapter 11. Company Profiles
11.1 Merck KGaA
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Charles River Laboratories
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Sartorius AG
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Lonza Group Ltd.
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 SGS S.A.
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Thermo Fisher Scientific Inc
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Wuxi Apptec
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Cytovance Biologics, Inc.
11.8.1 Overview
11.8.2 Product Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Avance Biosciences Inc.
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Eurofins Scientific
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Others

Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Biologics Safety Testing Industry

Chapter 13. Appendix

LIST OF TABLES
Table 1 Global Biologics Safety Testing Market Synopsis, 2018-2023
Table 2 Global Biologics Safety Testing Market Estimates and Forecast, 2018-2023
(USD Million)
Table 3 Global Biologics Safety Testing Market, by Region, 2018-2023 (USD Million)
Table 4 Global Biologics Safety Testing Market, by Product, 2018-2023 (USD Million)
Table 5 Global Biologics Safety Testing Market, by Test Type, 2018-2023 (USD Million)
Table 7 Global Biologics Safety Testing Market, by Application, 2018-2023 (USD Million)
Table 8 North America: Biologics Safety Testing Market, by Product, 2018-2023 (USD Million)
Table 9 North America: Biologics Safety Testing Market, by Test Type, 2018-2023 (USD Million)
Table 10 North America: Biologics Safety Testing Market, by Application, 2018-2023
(USD Million)
Table 11 US: Biologics Safety Testing Market, by Product, 2018-2023
(USD Million)
Table 12 US: Biologics Safety Testing Market, by Test Type, 2018-2023
(USD Million)
Table 13 US: Biologics Safety Testing Market, by Application, 2018-2023 (USD Million)
Table 14 Canada: Biologics Safety Testing Market, by Product, 2018-2023 (USD
Million)
Table 15 Canada: Biologics Safety Testing Market, by Test Type, 2018-2023 (USD
Million)
Table 16 Canada: Biologics Safety Testing Market, by Application, 2018-2023 (USD
Million)
Table 17 South America: Biologics Safety Testing Market, by Product, 2018-2023
(USD Million)
Table 18 South America: Biologics Safety Testing Market, by Test Type, 2018-2023
(USD Million)
Table 19 South America: Biologics Safety Testing Market, by Application, 2018-2023
(USD Million)
Table 20 Europe: Biologics Safety Testing Market, by Product, 2018-2023 (USD
Million)
Table 21 Europe: Biologics Safety Testing Market, by Test Type, 2018-2023 (USD
Million)
Table 22 Europe: Biologics Safety Testing Market, by Application, 2018-2023 (USD
Million)
Table 23 Western Europe: Biologics Safety Testing Market, by Product, 2018-
2023 (USD Million)
Table 24 Western Europe: Biologics Safety Testing Market, by Test Type, 2018-
2023 (USD Million)
Table 25 Western Europe: Biologics Safety Testing Market, by Application, 2018-2023
(USD Million)
Table 26 Eastern Europe: Biologics Safety Testing Market, by Product, 2018-
2023 (USD Million)
Table 27 Eastern Europe: Biologics Safety Testing Market, by Test Type, 2018-2023
(USD Million)
Table 28 Eastern Europe: Biologics Safety Testing Market, by Application, 2018-2023
(USD Million)
Table 29 Asia-Pacific: Biologics Safety Testing Market, by Product, 2018-2023
(USD Million)
Table 30 Asia-Pacific: Biologics Safety Testing Market, by Test Type, 2018-2023
(USD Million)
Table 31 Asia-Pacific: Biologics Safety Testing Market, by Application, 2018-2023 (USD
Million)
Table 32 Middle East & Africa: Biologics Safety Testing Market, by Product,
2018-2023 (USD Million)
Table 33 Middle East & Africa: Biologics Safety Testing Market, by Test Type, 2018-
2023 (USD Million)
Table 34 Middle East & Africa: Biologics Safety Testing Market, by Application, 2018-
2023 (USD Million)

LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Biologics Safety Testing Market
Figure 3 Segmentation Market Dynamics for Global Biologics Safety Testing Market
Figure 4 Global Biologics Safety Testing Market Share, by Product, 2017
Figure 5 Global Biologics Safety Testing Market Share, by Test Type, 2017
Figure 6 Global Biologics Safety Testing Market Share, by Application, 2017
Figure 7 Global Biologics Safety Testing Market Share, by Region, 2017
Figure 8 North America: Biologics Safety Testing Market Share, by Country, 2017
Figure 9 Europe: Biologics Safety Testing Market Share, by Country, 2017
Figure 10 Asia-Pacific: Biologics Safety Testing Market Share, by Country, 2017
Figure 11 Middle East & Africa: Biologics Safety Testing Market Share, by Country, 201
Figure 12 Global Biologics Safety Testing Market: Company Share Analysis, 2017 (%)
Figure 13 Merck KGaA: Key Financials
Figure 14 Merck KGaA: Segmental Revenue
Figure 15 Merck KGaA: Geographical Revenue
Figure 16 Charles River Laboratories: Key Financials
Figure 17 Charles River Laboratories: Segmental Revenue
Figure 18 Charles River Laboratories: Geographical Revenue
Figure 19 Sartorius AG: Key Financials
Figure 20 Sartorius AG: Segmental Revenue
Figure 21 Sartorius AG: Geographical Revenue
Figure 22 Lonza Group Ltd.: Key Financials
Figure 23 Lonza Group Ltd.: Segmental Revenue
Figure 24 Lonza Group Ltd.: Geographical Revenue
Figure 25 SGS S.A.: Key Financials
Figure 26 SGS S.A.: Segmental Revenue
Figure 27 SGS S.A.: Geographical Revenue
Figure 28 Thermo Fisher Scientific Inc: Key Financials
Figure 29 Thermo Fisher Scientific Inc.: Segmental Revenue
Figure 30 Thermo Fisher Scientific Inc.: Geographical Revenue
Figure 31 Wuxi Apptec: Key Financials
Figure 32 Wuxi Apptec: Segmental Revenue
Figure 33 Wuxi Apptec: Geographical Revenue
Figure 34 Cytovance Biologics, Inc.: Key Financials
Figure 35 Cytovance Biologics, Inc.: Segmental Revenue
Figure 36 Cytovance Biologics, Inc.: Geographical Revenue
Figure 37 Avance Biosciences Inc: Key Financials
Figure 38 Avance Biosciences Inc: Segmental Revenue
Figure 39 Avance Biosciences Inc: Geographical Revenue
Figure 40 Eurofins Scientific: Key Financials
Figure 41 Eurofins Scientific: Segmental Revenue
Figure 42 Eurofins Scientific: Geographical Revenue

発刊日

2018/12

体裁

PDF / 100ページ

販売価格

4,450USD

発行

Market Research Future

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

医薬品原料・製剤 / 医療器具・機器

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE